buprenorphine hydrochloride and naloxone hydrochloride

FDA Drug Profile — Zubsolv, Buprenorphine and Naloxone

buprenorphine hydrochloride and naloxone hydrochloride is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including Zubsolv, Buprenorphine and Naloxone. Available dosage forms: tablet, orally disintegrating, tablet.

Drug details

Generic Name
buprenorphine hydrochloride and naloxone hydrochloride
Brand Names
Zubsolv, Buprenorphine and Naloxone
Application Number
NDA204242
Sponsor
Orexo US, Inc.
NDC Codes
16
Dosage Forms
TABLET, ORALLY DISINTEGRATING, TABLET
Routes
SUBLINGUAL
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE ZUBSOLV is indicated for treatment of opioid dependence. ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ZUBSOLV contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. ( 1 ) ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.